Loading chat...

MS SB2119

Bill

Status

Passed

3/17/2021

Primary Sponsor

Joey Fillingane

Click for details

Origin

Senate

2021 Regular Session

AI Summary

  • Authorizes pharmacies to sell and individuals to purchase products containing up to 3.6 grams per day or 7.2 grams per 30-day period of pseudoephedrine or ephedrine without a prescription, effective January 1, 2022 through December 31, 2023.

  • Requires pharmacies to use the National Precursor Log Exchange (NPLEx) system before completing over-the-counter sales and maintain electronic transaction logs including purchaser identification, date, time, product name, and quantity sold.

  • Mandates purchasers be at least 18 years old with valid government-issued identification and sign a written or electronic record for each transaction; products must be stored behind pharmacy counters in restricted areas.

  • Establishes criminal penalties of up to $1,000 fine for first offense and up to $10,000 for subsequent offenses for violations; exempts pharmacists from penalties if employee training program approved by Mississippi Board of Pharmacy is documented.

  • Amends Mississippi Code Section 41-29-117 to exclude products sold under the quantity restrictions authorized by this act from Schedule III controlled substance classification; exempts prescription products from these requirements.

Legislative Description

Pseudoephedrine and ephedrine; authorize sales and purchase of certain products containing without a prescription.

Last Action

Approved by Governor

3/17/2021

Committee Referrals

Drug Policy2/24/2021
Drug Policy1/8/2021

Full Bill Text

No bill text available